Clinical Trials · NCT07535307
Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 80
- Start date
- Apr 2026
- Locations
- 1 site, Germany
- Primary endpoint
- Change in M-value in Hyperinsulinaemic euglycaemic clamp (HEC)